Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule
We examined the rat proximal tubule (PT) response to endothelin-1 (ET-1) in terms of 20-hydroxyeicosatetraenoic acid (HETE) dependency. Arachidonic acid (AA) (1 μM) decreased ouabain-sensitive 86Rb uptake from 2.1 ± 0.1 to 0.3 ± 0.08 ng Rb · 10 μg protein−1 · 2 min−1( P < 0.05); 20-HETE (1 μM) had similar effects. Dibromododecenoic acid (DBDD) (2 μM), an inhibitor of ω-hydroxylase, abolished the inhibitory action of AA on86Rb uptake whereas the PT response to 20-HETE was unaffected. ET-1 at 0.1, 1, 10, and 100 nM reduced 86Rb uptake from 2.8 ± 0.3 in control PTs to 2.4 ± 0.2, 1.7 ± 0.1, 0.67 ± 0.08, and 0.1 ± 0.03 ng Rb · 10 μg protein−1 · 2 min−1, respectively. DBDD (2 μM) abolished the inhibitory effect of ET-1 on86Rb uptake as did BMS182874 (1 μM), an ETA-selective receptor antagonist. ET-1 (100 nM) significantly increased PT 20-HETE release by ∼50%, an effect prevented by DBDD. N ω-nitro-l-arginine-methyl ester (l-NAME), given for 4 days to inhibit nitric oxide synthase (NOS), increased arterial pressure from 92 ± 12 to 140 ± 8 mmHg and increased endogenous release of 20-HETE from isolated PTs (measured by gas chromatography/mass spectrometry). Inl-NAME-treated PTs, but not in control PTs, 0.1 μM AA inhibited ouabain-sensitive 86Rb uptake by >40%; the response to AA was attenuated by DBDD. We conclude that, in the PTs, 1) 20-HETE is a second messenger for ET-1 and 2) conversion of AA to 20-HETE is augmented when NOS is inhibited.